Idaho Gold-Antimony Developer Wins $2.9B EXIM Loan Approval
Source: Streetwise Reports 08/21/2026
Perpetua Resources advances the Stibnite Gold Project in Idaho after securing a $2.9B U.S. EXIM loan and holding $574M cash, with construction targeted for a 2029 production start.
Perpetua Resources Corp. (PPTA:TSX; PPTA:NASDAQ) reached a major financing milestone with unanimous U.S. EXIM Board approval for a US$2.9 billion senior secured loan to support development of the Stibnite Gold Project in Idaho.
The approved financing, together with the company’s US$574.2 million of unrestricted cash at quarter-end, is expected to provide sufficient capital to cover the project’s estimated direct construction costs if the EXIM facility is finalized.
Perpetua is positioning itself as a domestic supplier of the critical mineral antimony while also developing one of the largest and highest-grade open-pit gold projects in the Americas and cleaning up an abandoned brownfield site in central Idaho.
Key Investor Takeaways
- The approved EXIM facility, together with US$574.2 million of unrestricted cash, is expected to cover the project’s estimated US$2.576 billion in direct capital costs if the loan is finalized.
- Final federal permits are in place, early construction has begun on the Burntlog Route and worker housing, and courts have issued rulings allowing construction activities to proceed while some legal proceedings remain pending.
- Exploration continues to deliver high-grade gold and antimony intercepts outside current pit designs, highlighting resource expansion potential.
- Perpetua is also pursuing U.S. government support for tungsten evaluation on its land package as a potential second critical mineral opportunity.
- Analyst price targets range from US$30 to US$43.50, reflecting the project’s scale, financing visibility, and critical-minerals exposure.
Why the Financing Milestone Matters Now
The unanimous EXIM approval on May 21 under the Make More in America Initiative represents a major financing milestone for the Stibnite Project. The facility is expected to become available after definitive documentation and satisfaction of customary conditions. Perpetua is now working through definitive documentation and expects to close the facility later this year.
With construction activities already underway on critical-path items such as the Burntlog Route access road, worker housing, and administrative facilities, the financing package gives the company a clear runway to maintain its 2029 production target.
Stibnite Project Advantages and Location
Located in Idaho, the wholly owned Stibnite Gold Project combines large-scale gold resources with a planned domestic antimony supply chain. The site benefits from an existing brownfield footprint that the company is rehabilitating while advancing detailed engineering and long-lead procurement.
Perpetua President and CEO Jon Cherry noted that the second quarter included the start of seasonal construction, ongoing deliveries of worker housing units, and continued exploration that returned promising high-grade results.
Exploration Catalysts and Next Steps
Perpetua’s July investor presentation highlighted existing intercepts outside the planned pits, including 49 meters at 5.42 g/t gold at Yellow Pine and 106 meters at 3.16 g/t gold at Hangar Flats. The July investor presentation also highlighted historical high-grade intercepts at exploration targets, including Garnet and Upper Midnight.
The company plans further step-out and definition drilling in 2026 to extend these zones and potentially upgrade inferred resources. Exploration or development activities outside the currently permitted project may require additional regulatory review and permitting.
Perpetua’s July 2026 investor presentation highlights multiple exploration opportunities around existing deposits and airborne targets that remain conceptual.
Sector Timing for Gold and Critical Minerals
Gold prices have experienced volatility, with spot gold recently trading near US$4,364.90 per ounce amid rising bond yields, according to a report by Sumit Saha on August 18. Longer-term forecasts remain constructive as central-bank buying and geopolitical factors support the metal.
The antimony market is expanding, with Fortune Business Insights projecting growth from US$1.22 billion in 2026 to US$2.01 billion by 2034 at a 5.80% CAGR, driven by flame retardants and defense applications amid concentrated Chinese supply.
Tungsten demand is also rising, with a July market report estimating the global market reaching US$6.66 billion in 2026. ChemAnalyst reported on August 7 that U.S. tungsten prices stabilized in July on tighter supply and growing interest in domestic projects.
Analyst Views and Valuation Context
On June 2, Roth Capital Partners’ Mike Niehuser reiterated a Buy rating and US$32.00 target, citing the EXIM loan and early construction progress. He noted that the financing plus cash provides coverage above the construction budget and highlighted remaining exploration upside at Hangar Flats and Yellow Pine.
On May 22, National Bank of Canada Capital Markets’ Rabi Nizami reiterated an Outperform rating and CA$55.00 target, emphasizing the financing buffer and 13-year loan maturity. He also flagged Stibnite as a potential M&A candidate given its scale and critical minerals importance.
Also on May 22, BMO Capital Markets’ Brian Quast maintained an Outperform rating and CA$47.00 target, noting that financing is expected to fully fund direct construction costs.
According to TipRanks, additional Buy ratings include RBC Capital at US$42, B. Riley Securities at US$30, and H.C. Wainwright’s Heiko Ihle, who reiterated a Buy at US$43.50 on August 18 (about 80.05% upside).
Share Structure and Near-Term Events1
Perpetua has 125.1 million shares issued and outstanding. On an undiluted basis, Paulson & Co. owns 25.86%, Agnico Eagle Mines Ltd. (AEM:TSX; AEM:NYSE) owns 6.4%, and JPMorganChase holds 2.23%. Institutions own about 47%, strategic investors about 6%, and insiders about 1%, with the balance held by retail investors. The stock trades in a 52-week range of CA$22.60 to CA$51.10 with a market capitalization of approximately CA$4.23 billion. [OWNERSHIP_CHART-10820]
Common Questions from Investors
What financing milestone was achieved? The U.S. EXIM Bank approved a US$2.9 billion senior secured loan on May 21, which the company expects to close later in 2026.
What is the current cash position? Perpetua ended the second quarter with US$574.2 million in unrestricted cash and US$60.9 million in restricted cash.
When is the final investment decision expected? Management has targeted the second half of 2026 for a final investment and construction decision.
What are the main upcoming catalysts? Closing the EXIM facility, continued exploration results, and reaching the final investment decision.
[SMNLINSERT]
Important Disclosures:
- Perpetua Resources Corp. is a billboard sponsor of Streetwise Reports. The company pays a monthly sponsorship fee of US$3,000–US$6,000 for banner advertising and an enhanced company profile page. Streetwise Reports’ editorial content is fully independent and is not influenced by sponsorship.
- Jordan Nova wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
1. Ownership and Share Structure Information
The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.
( Companies Mentioned: PPTA:TSX; PPTA:NASDAQ, )
Source: https://www.streetwisereports.com/article/2026/08/20/idaho-gold-antimony-developer-wins-2-9b-exim-loan-approval.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

